Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Dec 01, 2005 (Vol. 25, No. 21)

Science.ca Home

  • Some intersting reading
  • Too unfocused
The dot ‘ca' in the title tells us that it is a Canadian site, but the ‘Science' part is a bit ambiguous. It needn't be. Billing itself as the "Best source for Canadian science", Science.ca is a sort of billboard for all that is science in the great nation up north. Yes, that is a lot to expect of a site, and, to be honest, is more than can reasonably be delivered. Features, such as Ask a Scientist, cater to non–scientific audiences, so perhaps the aim here is to encourage young Canadians to pursue scientific careers. I can't argue with that, but I think a site like this one has more potential than it realizes. Narrowing the focus should do the trick.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »